Resources & Insights

Explore recent news within infectious disease in our latest Industry Round Up.

Learn more about PharPoint’s extensive infectious disease experience & expertise.

This March, we’re reading about ground-breaking T-cell therapy in multiple myeloma patients, new tumor-penetrating therapy to enhance chemotherapy, and the use of nano-probes to detect cancer.

Learn more about PharPoint’s experience with COVID-19 clinical trials.

Learn more about the journey clinical trial data takes before ending up on the package insert of a drug you’re taking.

PharPoint Research is thrilled to be a CRO Sponsor for the Spring 2021 Oncology Investor Conference. This event is the preeminent investment event in oncology – for investors seeking to invest in private and public cancer companies, and for cancer related companies seeking investment. 

As we move into March 2021, we explore three recent findings within infectious disease as part of our monthly Industry News Round-Up.

Ms. Will joins PharPoint as the company continues to grow and engage an increasing number of biotech and pharmaceutical clients seeking personalized attention, therapeutically aligned expertise, industry-best timelines, and decentralized study options.

In honor of Rare Disease Day 2021, PharPoint Research is diving into the facts, figures, and challenges surrounding rare diseases and rare disease clinical research.

This week, we’re looking at research on immunotherapy applications in kidney cancer, a potential prostate cancer test that could avoid unnecessary biopsies, and immunotherapy responses in various cancer treatments.